Literature DB >> 16367885

IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?

A Johansen1, D P Jensen, R Bergholdt, H B Mortensen, F Pociot, J Nerup, T Hansen, O Pedersen.   

Abstract

AIMS: Type 1 diabetes mellitus (T1DM) is a chronic disorder primarily triggered by environmental and immunological factors in genetically susceptible individuals. Despite the fact that there are indications of common aetiological features of T1DM and type 2 diabetes (T2DM), variation in genes involved in insulin secretion and insulin signalling has to a large extent been ignored as potential modifiers in the pathogenesis of T1DM. Recent studies suggest, however, that proven T2DM susceptibility gene variants may be involved in the pathogenesis of T1DM. The objective of this study was to estimate the impact of four selected amino acid polymorphisms -IRS-1 Gly972Arg, Kir6.2 Glu23Lys, HNF-1alpha Ala98Val and PPARgamma2 Pro12Ala in a Danish population of T1DM families.
METHODS: All variants were genotyped in 490 simplex- and multiplex-T1DM families applying polymerase chain reaction-restriction fragment length polymorphism, and results were evaluated by means of a transmission disequilibrium test (TDT) analysis.
RESULTS: TDT analysis revealed that the Arg972 IRS-1, the Lys23 Kir6.2 and the Val98 HNF-1alpha variants were transmitted from heterozygous parents to affected probands at frequencies of 49.1%, 47.0% and 54.1%, respectively (p > 0.05 for all). This was similar to the rate of transmission to unaffected siblings. The transmission rate of the Ala12 PPARgamma2 variant to affected probands was 46.5% (p > 0.05) which differed significantly from the transmission to unaffected offspring (p = 0.024). A combined analysis of the present and published pertinent data of 1691 transmissions showed a significantly decreased transmission of the PPARgamma2 Ala12 allele to affected probands (p = 0.0045).
CONCLUSIONS: The Pro12Ala variant of PPARgamma2 is associated with T1DM, the minor Ala allele conferring a reduced risk. This same finding has been reported in patients with T2DM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16367885     DOI: 10.1111/j.1463-1326.2005.00471.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  6 in total

1.  Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was.

Authors:  Marc Y Donath; Jan A Ehses
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

2.  Type 1 and type 2 diabetes-chalk and cheese?

Authors:  K R Owen; M I McCarthy
Journal:  Diabetologia       Date:  2009-08-01       Impact factor: 10.122

3.  No association of the IRS1 and PAX4 genes with type I diabetes.

Authors:  R Bergholdt; C Brorsson; B Boehm; G Morahan; F Pociot
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

Review 4.  Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.

Authors:  N K Loganadan; H Z Huri; S R Vethakkan; Z Hussein
Journal:  Pharmacogenomics J       Date:  2016-01-26       Impact factor: 3.550

5.  Impact of the Pro12Ala polymorphism of the PPAR-Gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients.

Authors:  S Ereqat; A Nasereddin; K Azmi; Z Abdeen; R Amin
Journal:  PPAR Res       Date:  2009-10-25       Impact factor: 4.964

6.  Association of hypoxia inducible factor-1 alpha gene polymorphism with both type 1 and type 2 diabetes in a Caucasian (Hungarian) sample.

Authors:  Geza Nagy; Reka Kovacs-Nagy; Eva Kereszturi; Aniko Somogyi; Anna Szekely; Nora Nemeth; Nora Hosszufalusi; Pal Panczel; Zsolt Ronai; Maria Sasvari-Szekely
Journal:  BMC Med Genet       Date:  2009-08-19       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.